Key result
Thrombomodulin activates NOS3 via a tyrosine kinase pathway to induce nitric oxide and calcium signals.
Why the study?
The mechanisms by which endothelial thrombomodulin transduces signals to activate endothelial nitric-oxide synthase and modulate G protein-coupled receptor signaling were unclear.
This study demonstrates that the cell surface thrombomodulin receptor mediates an outside-in signal to activate NOS3 through a tyrosine kinase-dependent pathway, potentially contributing to its function in thrombosis, inflammation, and atherosclerosis.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for thrombomodulin in vascular disease; leaves open translation to human thrombosis therapies.
Endothelial membrane-bound thrombomodulin is a high affinity receptor for thrombin to inhibit coagulation. We previously demonstrated that the thrombin-thrombomodulin complex restrains cell proliferation mediated through protease-activated receptor (PAR)-1. We have now tested the hypothesis that thrombomodulin transduces a signal to activate the endothelial nitric-oxide synthase (NOS3) and to modulate G protein-coupled receptor signaling. Cultured human umbilical vein endothelial cells were stimulated with thrombin or a mutant of thrombin that binds to thrombomodulin and has no catalytic activity on PAR-1. Thrombin and its mutant dose dependently activated NO release at cell surface. Pretreatment with anti-thrombomodulin antibody suppressed NO response to the mutant and to low thrombin concentration and reduced by half response to high concentration. Thrombin receptor-activating peptide that only activates PAR-1 and high thrombin concentration induced marked biphasic Ca2+ signals with rapid phosphorylation of PLC(beta3) and NOS3 at both serine 1177 and threonine 495. The mutant thrombin evoked a Ca2+ spark and progressive phosphorylation of Src family kinases at tyrosine 416 and NOS3 only at threonine 495. It activated rapid phosphatidylinositol-3 kinase-dependent NO synthesis and phosphorylation of epidermal growth factor receptor and calmodulin kinase II. Complete epidermal growth factor receptor inhibition only partly reduced the activation of phospholipase Cgamma1 and NOS3. Prestimulation of thrombomodulin did not affect NO release but reduced Ca2+ responses to thrombin and histamine, suggesting cross-talks between thrombomodulin and G protein-coupled receptors. This is the first demonstration of an outside-in signal mediated by the cell surface thrombomodulin receptor to activate NOS3 through tyrosine kinase-dependent pathway. This signaling may contribute to thrombomodulin function in thrombosis, inflammation, and atherosclerosis.
No takes yet. Share an insight, caveat, or question.
David‐Dufilho et al. (2005) studied this question. Thrombin and mutant thrombin was evaluated on Nitric oxide release and Ca2+ signals. Thrombomodulin transduces an outside-in signal to activate NOS3 through a tyrosine kinase-dependent pathway, inducing Ca2+ signals and nitric oxide synthesis.
Synapse has enriched 10 related papers. Consider them for comparative context: